This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Zosano Pharma Past Earnings Performance
Past criteria checks 0/6
Key information
-5.0%
Earnings growth rate
75.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 86.7% |
| Return on equity | -392.7% |
| Net Margin | -8,375.1% |
| Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02
Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Zosano Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 1 | -55 | 11 | 0 |
| 31 Dec 21 | 1 | -30 | 11 | 0 |
| 30 Sep 21 | 1 | -31 | 11 | 0 |
| 30 Jun 21 | 1 | -31 | 11 | 0 |
| 31 Mar 21 | 0 | -33 | 11 | 0 |
| 31 Dec 20 | 0 | -33 | 11 | 0 |
| 30 Sep 20 | 0 | -34 | 12 | 0 |
| 30 Jun 20 | 0 | -35 | 12 | 0 |
| 31 Mar 20 | 0 | -37 | 12 | 0 |
| 31 Dec 19 | 0 | -38 | 12 | 0 |
| 30 Sep 19 | 0 | -39 | 11 | 0 |
| 30 Jun 19 | 0 | -37 | 10 | 0 |
| 31 Mar 19 | 0 | -37 | 10 | 0 |
| 31 Dec 18 | 0 | -35 | 9 | 0 |
| 30 Sep 18 | 0 | -33 | 9 | 0 |
| 30 Jun 18 | 0 | -32 | 8 | 0 |
| 31 Mar 18 | 0 | -30 | 8 | 0 |
| 31 Dec 17 | 0 | -29 | 8 | 0 |
| 30 Sep 17 | 0 | -29 | 8 | 0 |
| 30 Jun 17 | 0 | -29 | 8 | 0 |
| 31 Mar 17 | 0 | -29 | 8 | 0 |
| 31 Dec 16 | 0 | -30 | 8 | 0 |
| 30 Sep 16 | 0 | -30 | 8 | 0 |
| 30 Jun 16 | 0 | -31 | 7 | 0 |
| 31 Mar 16 | 0 | -32 | 7 | 0 |
| 31 Dec 15 | 0 | -28 | 6 | 0 |
Quality Earnings: ZSAN.Q is currently unprofitable.
Growing Profit Margin: ZSAN.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZSAN.Q is unprofitable, and losses have increased over the past 5 years at a rate of 5% per year.
Accelerating Growth: Unable to compare ZSAN.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZSAN.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10%).
Return on Equity
High ROE: ZSAN.Q has a negative Return on Equity (-392.74%), as it is currently unprofitable.